Literature DB >> 22236847

Prevalence of latent tuberculosis infection in inmates recently incarcerated in a men's prison in Barcelona.

A Marco1, N Solé, A Orcau, M Escribano, L del Baño, S Quintero, J A Caylà.   

Abstract

OBJECTIVE: To study the prevalence of latent tuberculosis infection (LTBI) in prisoners.
METHODS: Among inmates admitted to a men's preventive detention prison in Barcelona during May-June 2009, without a previous positive tuberculin skin test (TST), a ≥ 10 mm TST was considered positive (5 mm in human immunodeficiency virus [HIV] infected persons). A multivariate logistic regression was performed, calculating odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS: A total of 221 individuals were included. The average age was 33.5 years (± 8.9 SD); 61.6% were foreigners and 45.2% were heroine and/or cocaine users; 40.3% had LTBI. The infection was associated with age >40 years (OR 3.10, 95%CI 1.51-6.35) and having been born in Eastern Europe (OR 4.3, 95%CI 1.4-12.8), North Africa (OR 2.2, 95%CI 1.01-4.7), sub-Saharan Africa (OR 7.6, 95%CI 1.3-44) or Latin America (OR 3.8, 95%CI 1.5-9.3). Subjects infected with HIV had a lower risk of a positive TST (OR 0.22, 95%CI 0.04-1.07). Only 31 (14%) did not present any of these risk factors, and 8 (25.8%) had LTBI.
CONCLUSIONS: The prevalence of LTBI was very high in this study, and systematic screening of all inmates at the time of entry into the prison is therefore recommended. Excluding those who do not fall in any of the high-risk prevalence groups from the evaluation complicates the screening and is not very effective.

Entities:  

Mesh:

Year:  2012        PMID: 22236847     DOI: 10.5588/ijtld.11.0007

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  9 in total

1.  Prevalence of tuberculosis symptoms and latent tuberculous infection among prisoners in northeastern Malaysia.

Authors:  B Margolis; H A A Al-Darraji; J A Wickersham; A Kamarulzaman; F L Altice
Journal:  Int J Tuberc Lung Dis       Date:  2013-12       Impact factor: 2.373

2.  Basic characteristics for a good tuberculosis prevention and control programmes currently in Spain.

Authors:  J P Millet
Journal:  Rev Esp Sanid Penit       Date:  2021 Jan-Apr

Review 3.  Hispano-Americans in Europe: what do we know about their health status and determinants? A scoping review.

Authors:  Maria Roura; Andreu Domingo; Juan M Leyva-Moral; Robert Pool
Journal:  BMC Public Health       Date:  2015-05-07       Impact factor: 3.295

4.  Latent tuberculosis infection in a Malaysian prison: implications for a comprehensive integrated control program in prisons.

Authors:  Haider Abdulrazzaq Abed Al-Darraji; Adeeba Kamarulzaman; Frederick L Altice
Journal:  BMC Public Health       Date:  2014-01-10       Impact factor: 3.295

5.  Prevalence of latent Mycobacterium tuberculosis infection in prisoners.

Authors:  Pedro Daibert de Navarro; Isabela Neves de Almeida; Afrânio Lineu Kritski; Maria das Graças Ceccato; Mônica Maria Delgado Maciel; Wânia da Silva Carvalho; Silvana Spindola de Miranda
Journal:  J Bras Pneumol       Date:  2016 Sep-Oct       Impact factor: 2.624

6.  Prevalence of latent tuberculosis infection and associated risk factors in prison in East Wollega Zone of western Ethiopia.

Authors:  Basha Chekesa; Balako Gumi; Mahlet Chanyalew; Aboma Zewude; Gobena Ameni
Journal:  PLoS One       Date:  2020-05-19       Impact factor: 3.240

7.  Prevalence of reactivity to the tuberculin test and associated factors in the population attended at a drug addiction center in the period 2013-2016.

Authors:  E Castellanos-García; M A Carrillo-Conde
Journal:  Rev Esp Sanid Penit       Date:  2018 May-Aug

8.  Prevalence and associated risk factors of latent tuberculosis infection in a Spanish prison.

Authors:  M E López de Goicoechea-Saiz; F Sternberg; J Portilla-Sogorb
Journal:  Rev Esp Sanid Penit       Date:  2018

9.  From control of tuberculosis to control of infection: WHO recommendations for low-prevalence countries.

Authors:  S Manzanares-Laya; M Jané Checa
Journal:  Rev Esp Sanid Penit       Date:  2019 Jan-Apr
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.